ecancer

Germ line predisposition to leukaemia

Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA

27 Apr 2016

The future of haematopathology

Prof Alberto Zamo - University of Verona, Verona, Italy

27 Apr 2016

Frontline therapy in young patients with myeloma

Prof Philippe Moreau - University of Nantes, Nantes, France

27 Apr 2016

Genomics of childhood ALL

Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel

27 Apr 2016

Non-coding mutations driving chronic lymphocytic leukaemia

Dr Xose Puente - University of Oviedo, Oviedo, Spain

27 Apr 2016

BSH 2016: Expert discussion on front line care in CLL

Dr George Follows and Dr Andrew Zelenetz

27 Apr 2016

BSH 2016: Expert discussion on idelalisib

Dr George Follows and Dr Andrew Zelenetz

27 Apr 2016

Normal and neoplastic stem cells

Prof Irving L Weissman - Stanford University School of Medicine, Stanford, USA

26 Apr 2016

Management of CLL patients in the front-line setting: live broadcast

Dr Catherine Hood, Dr Robin Foà, Dr Patrick Thornton, and Prof Stephan Stilgenbauer

19 Apr 2016

Update on new agents in multiple myeloma – focus on monoclonal antibodies: an expert roundtable discussion

Michel Delforge, Hermann Einsele, Philippe Moreau and Niels van de Donk

19 Apr 2016

Novel agents before and after stem cell transplantation for myeloma

Dr Enrique Ocio - Universidad de Salamanca, Salamanca, Spain

12 Apr 2016

EBMT 2016 Highlights: Expert discussion

Prof Paul Richardson and Prof Mohamad Mohty

11 Apr 2016

More from ecancer